Malfertheiner, Peter, 1950-....
Malfertheiner, P. (Peter), 1950-
Malfertheiner, P.
Malfertheiner, P. (Peter)
Peter Malfertheiner researcher
VIAF ID: 111519306 ( Personal )
Permalink: http://viaf.org/viaf/111519306
Preferred Forms
- 200 _ | ‡a Malfertheiner ‡b Peter ‡f 1950-....
-
-
-
- 100 1 _ ‡a Malfertheiner, P. ‡q (Peter)
-
-
- 100 1 _ ‡a Malfertheiner, P. ‡q (Peter), ‡d 1950-
-
- 100 1 _ ‡a Malfertheiner, Peter ‡d 1950-
- 100 1 _ ‡a Malfertheiner, Peter ‡d 1950-
- 100 1 _ ‡a Malfertheiner, Peter ‡d 1950-
-
- 100 1 _ ‡a Malfertheiner, Peter, ‡d 1950-....
- 100 0 _ ‡a Peter Malfertheiner ‡c researcher
4xx's: Alternate Name Forms (11)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Acid inhibition and peptic ulcer 100 years of Carl Schwarz's dictum: no acid - no ulcer ; EAGE postgraduate course, November 5 - 6, 2010, Zagreb, Croatia ; 14 tables | |
Aging and the gastrointestinal tract | |
Aktuelle Aspekte zur Pathogenese und Therapie des peptischen Magen- und Duodenalulcus | |
Basic mechanisms of digestive diseases the rationale for clinical management and prevention | |
Campylobacter pylori in gastroduodenal diseases : current views - future directions : proceedings of an International Workshop in Copenhagen October 15 and 16, 1987 | |
Challenges in inflammatory, preneoplastic and neoplastic diseases of the digestive system 19 tables | |
Chronische Pankreatitis ein Beitrag zu ihrer Diagnose und Charakterisierung durch morphologische und funktionelle moderne Testverfahren | |
Clinical pancreatology for practising gastroenterologists and surgeons | |
Diagnostic procedures in pancreatic disease | |
Diseases of the pancreas : acute pancreatitis, chronic pancreatitis, neoplasms of the pancreas | |
Erkrankungen des Pankreas : Evidenz in Diagnostik, Therapie und Langzeitverlauf | |
Fusobacterium nucleatum is associated with worse prognosis in Lauren´s diffuse type gastric cancer patients | |
Gastric and gut microbiota in health and disease | |
gastrointestinale Mikrobiom Wechselspiel von Kommensalität und Pathogenität | |
Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID) | |
Gut microbiota: the forgotten organ EAGE postgraduate course, March 17 - 18, 2011, Sorrento ; 16 tables | |
H. PYLORI ERADICATION HAS THE POTENTIAL TO PREVENT GASTRIC CANCER | |
Helicobacter pylori Epidemiologie, Pathogenese, Diagnostik, Klinik, Therapie | |
Helicobacter pylori, Gastritis and Peptic Ulcer | |
Helicobacter pylori infection new facts - new views | |
Helicobacter pylori - od podstaw do leczenia : cechy charakterystyczne, patogeneza, wykrywanie, eradykacja | |
Helicobacter pylori von der Grundlage zur Therapie ; Eigenschaften, Pathogenese, Nachweis, Eradikation ; 52 Tabellen | |
Karzinom am ösophagogastralen Übergang | |
Liver cell cancer | |
Maintenance therapy with FOLFIRI after FOLFIRINOX for advanced pancreatic ductal adenocarcinoma : a retrospective single-center analysis | |
Management of portal hypertension 20 tables | |
Metabolic and autoimmune diseases of the digestive system selected articles from the EAGE postgraduate courses Opatija and Prag 2011 ; 14 tables | |
Molecular medicine in gastrointestinal oncology EAGE postgraduate courses Budapest, May 26 - 28, 2011 ; 14 tables | |
Pancreatic cancer an update ; 17 tables | |
Pankreaserkrankungen akute Pankreatitis, chronische Pankreatitis, Tumore des Pankreas ; 87 Tabellen | |
Pankreatin Enzymsubstitution bei exokriner Pankreasinsuffizienz | |
The pH-Hp challenge - from mechanism to management : proceedings of a symposium held in Copenhagen, Denmark, 29 April 1995 | |
Proton pump inhibitors a balanced view | |
The Regulation of cell proliferation and differentiation : from basic science to clinical implications | |
Review : prevention and management of gastric cancer | |
Standards and innovations in gastrointestinal endoscopy 28 tables | |
Standards in pancreatic surgery | |
Update gastroenterology 2006 novel developments in gastroenterology | |
Vergleich der Effektivität von CT-gesteuerter Brachytherapie gegenüber transarterieller Chemoembolisation bei Patienten mit inoperablem HCC Interimsanalyse zur entgültigen Fallzahlplanung einer randomisierten Phase-III-Studie |